Showing results (181-190 of 264) with videos related to

Sort By:
Pageof 27
Annals of the New York Academy of Sciences|September 18, 2009
TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practiceAntonio Marchesoni, Eleonora Zaccara, Roberto Gorla, et al.
Autoimmunity Reviews|August 4, 2009
Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registryFrancesca Bobbio Pallavicini, Roberto Caporali, Piercarlo Sarzi-Puttini, et al.
Clinical Reviews in Allergy & Immunology|June 24, 2009
Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational studyMatteo Filippini, Chiara Bazzani, Ennio Giulio Favalli, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 4, 2018
Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: A case reportG Fanetti, F Bazzani, A Ferrari, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2001
Protective effect of melanocortin peptides in rat myocardial ischemiaC Bazzani, S Guarini, A R Botticelli, et al.
Food Research International (Ottawa, Ont.)|November 27, 2024
Screening the carotenoid in vitro bioaccessibility of purple corn breakfast cereal consumed with milk and plant-based milkCelso Andrade Camargo, Rebeca Salvador-Reyes, Carmen Sílvia Rincon Bazzani, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 24, 2023
Finger ischemia in a young lady: an unusual presentation of papillary fibroelastoma with intraventricular locationMatteo Pernigo, Elisabetta Dinatolo, Marco Cirillo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptidesS Guarini, C Bazzani, M M Cainazzo, et al.
Surgery|January 29, 2002
Evidence for a role of nuclear factor-kappaB in acute hypovolemic hemorrhagic shockDomenica Altavilla, Antonino Saitta, Giovanni Squadrito, et al.
Cardiovascular Research|September 15, 2001
Nuclear factor-kappaB as a target of cyclosporin in acute hypovolemic hemorrhagic shockD Altavilla, A Saitta, S Guarini, et al.
Pageof 27